A 'benign' extrapyramidal side effect masking a life-threatening neuroleptic malignant syndrome
- PMID: 32968424
- PMCID: PMC7501023
- DOI: 10.12669/pjms.36.6.2963
A 'benign' extrapyramidal side effect masking a life-threatening neuroleptic malignant syndrome
Abstract
The neuroleptic malignant syndrome is a rare, life-threatening idiosyncratic reaction to neuroleptic medication. The use of newer antipsychotics combined with its rare incidence has made NMS seem as a complication of the past. Here we report a patient in his early 20s suffering from a psychotic disorder developing a life-threatening neuroleptic malignant syndrome on an inpatient psychiatric ward in Canada without the characteristic overt change in autonomic stability. We review the clinical characteristics to facilitate the early recognition of neuroleptic malignant syndromes and discuss why this condition still is highly relevant for practising physicians.
Keywords: Antipsychotics; EPSE; Extra-pyramidal side effects; NMS; Neuroleptic malignant syndrome; Neuroleptics.
Copyright: © Pakistan Journal of Medical Sciences.
Conflict of interest statement
Conflict of Interests: The authors have no conflict of interests to report.
Similar articles
-
[Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].Encephale. 2008 Dec;34(6):618-24. doi: 10.1016/j.encep.2007.11.007. Epub 2008 Apr 2. Encephale. 2008. PMID: 19081460 Review. French.
-
Olanzapine-Induced Neuroleptic Malignant Syndrome.Iran J Med Sci. 2017 May;42(3):306-309. Iran J Med Sci. 2017. PMID: 28533580 Free PMC article.
-
Neuroleptic malignant syndrome: a review for neurohospitalists.Neurohospitalist. 2011 Jan;1(1):41-7. doi: 10.1177/1941875210386491. Neurohospitalist. 2011. PMID: 23983836 Free PMC article.
-
Side effects of antipsychotic agents--neuroleptic malignant syndrome.Med Pregl. 2010 Sep-Oct;63(9-10):705-8. doi: 10.2298/mpns1010705c. Med Pregl. 2010. PMID: 21443058
-
[Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS].Ugeskr Laeger. 2000 Mar 6;162(10):1366-70. Ugeskr Laeger. 2000. PMID: 10745673 Review. Danish.
References
-
- Shalev A, Hermesh H, Munitz H. Mortality from neuroleptic malignant syndrome. J Clin Psychiatry. 1989;50:18–25. - PubMed
-
- Velamoor R. Neuroleptic malignant syndrome:A neuro-psychiatric emergency:Recognition, prevention, and management. Asian J Psychiatr. 2017;29:106–109. - PubMed
-
- Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry. 1985;142:1137–1145. - PubMed
-
- Gurrera RJ, Caroff SN, Cohen A, Carroll BT, DeRoos F, Francis A, et al. An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method. J Clin Psychiatry. 2011;72:1222–1228. doi:10.4088/JCP.10m06438. - PubMed
-
- Nisijima K. Serotonin syndrome overlapping with neuroleptic malignant syndrome:A case report and approaches for differentially diagnosing the two syndromes. Asian J Psychiatr. 2015;18:100–101. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous